Exact Mass: 346.0791

Exact Mass Matches: 346.0791

Found 64 metabolites which its exact mass value is equals to given mass value 346.0791, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

adenosine 5-phosphoramidate

adenosine 5-phosphoramidate

C10H15N6O6P (346.0791)


The phosphoramadite analogue of AMP.

   

3-Amino-3-deoxy-AMP

3-Amino-3-deoxyadenosine 5-(dihydrogen phosphate)

C10H15N6O6P (346.0791)


   

N1-(2-Hydroxyethyl)flurazepam

7-chloro-5-(2-fluorophenyl)-1-(2-methoxyethyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C18H16ClFN2O2 (346.0884)


N1-(2-Hydroxyethyl)flurazepam is a metabolite of flurazepam. Flurazepam (marketed under the brand names Dalmane and Dalmadorm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It produces a metabolite with a very long half-life (40–250 hours), which may stay in the bloodstream for up to four days. http://www. non-benzodiazepines. org. uk/equivalents. html Flurazepam is therefore unsuitable as a sleeping medication for some individuals due to next day sedation. (Wikipedia)

   

3-O-Methylfluorescein

3-hydroxy-6-methoxy-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H14O5 (346.0841)


   

Hydroxydehydro Nifedipine Carboxylate

2-(hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)pyridine-3-carboxylic acid

C16H14N2O7 (346.0801)


   

Raclopride

3,5-Dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzene-1-carboximidate

C15H20Cl2N2O3 (346.0851)


   
   

Maybridge1_000533

Maybridge1_000533

C21H15ClN2O (346.0873)


   
   

3,5-dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzamide

3,5-dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzamide

C15H20Cl2N2O3 (346.0851)


   
   
   
   

SCHEMBL17867190

SCHEMBL17867190

C21H14O5 (346.0841)


   

Wailupemycin G

Wailupemycin G

C21H14O5 (346.0841)


   

Raclopride

Raclopride

C15H20Cl2N2O3 (346.0851)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Raclopride is a dopamine D2/D3 receptor antagonist with potential antipsychotic effects. Raclopride binds to D2 and D3 receptors with Kis of 1.8 nM and 3.5 nM, respectively[1][2].

   

3,5-Pyridinedicarboxylic acid, 2-(hydroxymethyl)-6-methyl-4-(2-nitrophenyl)-, 5-methyl ester

3,5-Pyridinedicarboxylic acid, 2-(hydroxymethyl)-6-methyl-4-(2-nitrophenyl)-, 5-methyl ester

C16H14N2O7 (346.0801)


   

Propylthiouracil glucuronide

Propylthiouracil glucuronide

C13H18N2O7S (346.0835)


   

Gly-Tyr-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)-3-(4-hydroxyphenyl)propanoic acid

C16H14N2O7 (346.0801)


   

(5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

(5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

C15H20Cl2N2O3 (346.0851)


   

3,4-bis(2,4,5-trimethylthiophen-3-yl)furan-2,5-dione

3,4-bis(2,4,5-trimethylthiophen-3-yl)furan-2,5-dione

C18H18O3S2 (346.0697)


   

(5S)-(-)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

(5S)-(-)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

C15H20Cl2N2O3 (346.0851)


   

UNII:536V290790

Mabuterol hydrochloride

C13H19Cl2F3N2O (346.0826)


   

2-ETHOXY-5-[(PIPERIDINE-1-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

2-ETHOXY-5-[(PIPERIDINE-1-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

C14H19ClN2O4S (346.0754)


   

1-(5-chloro-2-nitrophenyl)-3,4-dihydro-6,7-dimethoxyisoquinoline

1-(5-chloro-2-nitrophenyl)-3,4-dihydro-6,7-dimethoxyisoquinoline

C17H15ClN2O4 (346.072)


   

2,2-[1,2-Phenylenebis(oxy)]bis(1,3,2-benzodioxaborole)

2,2-[1,2-Phenylenebis(oxy)]bis(1,3,2-benzodioxaborole)

C18H12B2O6 (346.082)


   

Raclopride C 11

Raclopride C 11

C15H20Cl2N2O3 (346.0851)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

4-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1]benzofuro[3,2-d]pyrimidine

4-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1]benzofuro[3,2-d]pyrimidine

C19H14N4OS (346.0888)


   

2,6-Diaminopurine nucleotide

2,6-Diaminopurine nucleotide

C10H15N6O6P (346.0791)


   

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-YL)-3,4-dihydroxytetrahydro-2-furanyl]methyl sulfamate

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-YL)-3,4-dihydroxytetrahydro-2-furanyl]methyl sulfamate

C10H14N6O6S (346.0696)


   

(3e)-5-Fluoro-1-[(6-Fluoro-4h-1,3-Benzodioxin-8-Yl)methyl]-1h-Indole-2,3-Dione 3-Oxime

(3e)-5-Fluoro-1-[(6-Fluoro-4h-1,3-Benzodioxin-8-Yl)methyl]-1h-Indole-2,3-Dione 3-Oxime

C17H12F2N2O4 (346.0765)


   

4-[(E)-[5-chloro-3-methyl-1-(4-methylphenyl)pyrazol-4-yl]methylideneamino]-3-methyl-1H-1,2,4-triazole-5-thione

4-[(E)-[5-chloro-3-methyl-1-(4-methylphenyl)pyrazol-4-yl]methylideneamino]-3-methyl-1H-1,2,4-triazole-5-thione

C15H15ClN6S (346.0767)


   

4-[(2E)-2-[(E)-3-(2-nitrophenyl)prop-2-enylidene]hydrazinyl]benzenesulfonamide

4-[(2E)-2-[(E)-3-(2-nitrophenyl)prop-2-enylidene]hydrazinyl]benzenesulfonamide

C15H14N4O4S (346.0736)


   

7-chloro-5-(4-fluorophenyl)-4-(1-oxopropyl)-3,5-dihydro-1H-1,4-benzodiazepin-2-one

7-chloro-5-(4-fluorophenyl)-4-(1-oxopropyl)-3,5-dihydro-1H-1,4-benzodiazepin-2-one

C18H16ClFN2O2 (346.0884)


   

(2S,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2S,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2R,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile

(2R,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile

C17H15FN2O3S (346.0787)


   

(2R,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2R,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2S,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2S,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2R,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2R,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2S,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2S,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2S,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2S,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

(2R,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

(2R,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile

C17H15FN2O3S (346.0787)


   

Cephalexin(1-)

Cephalexin(1-)

C16H16N3O4S- (346.0861)


The anion resulting from the removal of a proton from the carboxylic acid group of cephalexin.

   

2-hydroxy-3-[3-[(E)-4-hydroxy-3-methylbut-2-enyl]-4-sulooxyphenyl]propanoic acid

2-hydroxy-3-[3-[(E)-4-hydroxy-3-methylbut-2-enyl]-4-sulooxyphenyl]propanoic acid

C14H18O8S (346.0722)


   

2,3-Dihydroxy-3-[3-(3-methylbut-2-enyl)-4-sulooxyphenyl]propanoic acid

2,3-Dihydroxy-3-[3-(3-methylbut-2-enyl)-4-sulooxyphenyl]propanoic acid

C14H18O8S (346.0722)


   

Hydroxydehydro Nifedipine Carboxylate

Hydroxydehydro Nifedipine Carboxylate

C16H14N2O7 (346.0801)


   

N1-(2-Hydroxyethyl)flurazepam

N1-(2-Hydroxyethyl)flurazepam

C18H16ClFN2O2 (346.0884)


   
   

3'-Amino-3'-deoxy-AMP

3'-Amino-3'-deoxy-AMP

C10H15N6O6P (346.0791)


   
   
   
   

(2s)-6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

(2s)-6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

C21H14O5 (346.0841)


   

6-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-4-hydroxypyran-2-one

6-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-4-hydroxypyran-2-one

C21H14O5 (346.0841)


   

2-(2,3-dihydroxyphenyl)-n-hydroxy-n-[2-(3h-imidazol-4-yl)ethyl]-1,3-thiazole-4-carboxamide

2-(2,3-dihydroxyphenyl)-n-hydroxy-n-[2-(3h-imidazol-4-yl)ethyl]-1,3-thiazole-4-carboxamide

C15H14N4O4S (346.0736)


   

6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

C21H14O5 (346.0841)


   

(1s,2s,5r,7s,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

(1s,2s,5r,7s,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

C15H23BrO4 (346.078)


   

(1s,2r,5r,7r,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

(1s,2r,5r,7r,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

C15H23BrO4 (346.078)


   

5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

C15H23BrO4 (346.078)


   

2-{7-oxo-2h,3h-furo[3,2-g]chromen-2-yl}propan-2-yl (2z)-3-(methylsulfanyl)prop-2-enoate

2-{7-oxo-2h,3h-furo[3,2-g]chromen-2-yl}propan-2-yl (2z)-3-(methylsulfanyl)prop-2-enoate

C18H18O5S (346.0875)


   

2-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-6-hydroxypyran-4-one

2-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-6-hydroxypyran-4-one

C21H14O5 (346.0841)


   

(1s,7r,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

(1s,7r,9r,10s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

C15H23BrO4 (346.078)


   

(2s,5r,7s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

(2s,5r,7s,12s)-5-bromo-2,4,4,10-tetramethyl-3,8,14-trioxatetracyclo[7.3.1.1⁷,¹⁰.0²,⁷]tetradecan-12-ol

C15H23BrO4 (346.078)